Symbols

SLGC(Delisted)

SomaLogic·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SLGC

Somalogic, Inc.

A leader in AI-data driven proteomics technology

Industry

Established Date

12/15/2020

Listing Date

04/23/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

451

Fiscal Year Ends

12-31

Website

www.somalogic.com

Security Type

Common stock

Office address

2945 Wilderness Place, Boulder, CO 80301

Business

Introduction

SomaLogic, Inc., was incorporated as a Delaware corporation on December 15, 2020. SomaLogic seeks to provide accurate, meaningful and actionable health management information that enables individuals around the world to continuously optimize their personal health and wellness throughout their lives. Derived from SomaLogic's personalized measurements of individual protein changes over time, this important information will be provided through a global network of partners and users.

Company Financials

EPS

SLGC has released its 2023 Q3 earnings. EPS was reported at -0.12, versus the expected -0.17, beating expectations. The chart below visualizes how SLGC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SLGC has released its 2023 Q3 earnings report, with revenue of 22.05M, reflecting a YoY change of -47.14%, and net profit of -22.16M, showing a YoY change of 32.74%. The Sankey diagram below clearly presents SLGC's revenue sources and cost distribution.